Cell-Based Immunotherapies

New for 2020, The Cell-Based Immunotherapy stream focuses on the latest protein engineering, clinical and analytical strategies driving the development of cell-based immunotherapies such as CAR Ts, TCRs, TILs and NKs, for the treatment of cancer and immune disorders. Topics include improving target identification, optimizing product design, specificity, safety, characterization and analytics.

Conferences Include:

August 31 - September 1

Improving Immunotherapy Efficacy and Safety

September 2-3

CAR Ts, TCRs and TILs

September 3-4

Cell and Gene Therapy Analytics

Keynote Speakers:


Prasad Adusumilli, MD, FACS, FCCP, Deputy Chief and Associate Attending, Thoracic Surgery; Director, Mesothelioma

Adrian Bot, PhD, Vice President, Translational Medicine, Kite Pharma, a Gilead Company

Jan Joseph (Jos) Melenhorst, PhD Adjunct Associate Professor, Pathology & Laboratory Medicine, University of Pennsylvania

Jeffrey Miller, MD, Professor of Medicine, Deputy Director, Masonic Cancer Center, Division of Hematology, Oncology and Transplantation, University of Minnesota

Register Now

View By:

Premier Sponsors

FairJourneyBiologics GenScript-CRO Integral-Molecular_NEWLONZAOmniAb  Samsung_Biologics TWIST-Bioscience UnchainedLabs